柏柏林通过抑制细胞因子分泌和调节肺微生物群来缓解T细胞驱动的肺炎
Ziqing Ma1, Yu Zhou2, Fudie Gu1
1College of Ocean Food and Biological Engineering, Xiamen Key Laboratory of Marine Functional Food, Fujian Provincial Engineering Technology Research Center of Marine Functional Food, Jimei University, Xiamen 361021, Fujian, China.
Biochemical and biophysical research communications
|July 27, 2025
概括
柏柏林抑制CD4+T细胞的激活和分化,减少肺炎. 它调节关键信号通路和肺微生物群,为炎症性疾病提供治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 柏柏林因其抗炎性质而闻名,但它对CD4+T细胞及其潜在机制的直接影响尚未完全理解.
- CD4+ T 细胞在调节免疫反应和炎症疾病方面发挥着至关重要的作用.
研究的目的:
- 研究柏柏林在体外和体外对CD4+T细胞分化和功能的直接作用和机制.
- 在肺炎模型中评估柏柏林的治疗潜力.
主要方法:
- 使用OVA刺激的T细胞进行体外研究,以评估T细胞激活,增殖,亡和细胞因子的产生.
- 转录组分析以确定由柏柏林调节的信号通路.
- 在体内实验中,使用OVA特异性T细胞介导的肺炎的小鼠模型进行实验.
- 分析肺部微生物群的组成和多样性.
主要成果:
- 柏柏林直接抑制了Th1和Th17的分化,抑制了T细胞的激活和增殖,并通过降低Bcl2的调节来适度诱导细胞亡.
- 柏柏林调节了JAK-STAT,PI3K/Akt和NF-κB信号通路,PTEN抑制逆转了这些影响.
- 在体内,柏柏林显著降低了肺炎,CD4+T细胞透和肺中的细胞因子产生.
- 柏柏林改变了肺部微生物群的多样性,但没有影响总体细菌的数量,这可能有助于其抗炎作用.
结论:
- 柏柏林直接向CD4+T细胞,抑制其功能和分化,改善肺炎.
- 柏柏林的治疗作用包括调节关键的细胞内信号通路和肺微生物群.
- 柏柏林通过抑制T细胞介导反应,对炎症性肺病具有显著的治疗潜力.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314


